Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Biochem ; 267(1): 269-75, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10601876

RESUMO

The skin secretions of female and male Litoria splendida have been monitored monthly over a three-year period using HPLC and electrospray mass spectrometry. Two minor peptides are present only in the skin secretion of the male. The first of these is the female-attracting aquatic male sex pheromone that we have named splendipherin, a 25 amino acid peptide (GLVSSIGKALGGLLADVVKSKGQPA-OH). This pheromone constitutes about 1% of the total skin peptides during the breeding season (January to March), dropping to about 0.1% during the period June to November. Splendipherin attracts the female in water at a concentration of 10-11-10-9 M, and is species specific. The second peptide is a wide-spectrum antibiotic of the caerin 1 group, a 25 residue peptide (GLLSVLGSVAKHVLPHVVPVIAEKL-NH2) named caerin 1.10. The neuropeptides of L. splendida are also seasonally variable, the change identical for both the female and male. During the period October to March, the sole neuropeptide present in skin secretions is caerulein [pEQDY(SO3)TGWMDF-NH2]; this is active on smooth muscle and is also an analgaesic. During the southern winter (June to September), more than half of the caerulein is hydrolysed to [pEQDYTGWMDF-NH2], a peptide that shows no smooth muscle activity. In place of caerulein, a new peptide, Phe8 caerulein [pEQDY(SO3)TGWFDF-NH2], becomes a major component of the skin secretion. Perhaps this seasonal change is involved in thermoregulation, that is, with the initiation and maintenance of the inactive (hibernation) phase of the animal.


Assuntos
Bufonidae/metabolismo , Ceruletídeo/análogos & derivados , Fragmentos de Peptídeos/metabolismo , Feromônios/metabolismo , Caracteres Sexuais , Pele/metabolismo , Sequência de Aminoácidos , Animais , Anti-Infecciosos/síntese química , Anti-Infecciosos/química , Anti-Infecciosos/metabolismo , Anti-Infecciosos/farmacologia , Austrália , Comportamento Animal/efeitos dos fármacos , Bufonidae/fisiologia , Ceruletídeo/síntese química , Ceruletídeo/química , Ceruletídeo/metabolismo , Ceruletídeo/farmacologia , Cromatografia Líquida de Alta Pressão , Relação Dose-Resposta a Droga , Feminino , Masculino , Espectrometria de Massas , Dados de Sequência Molecular , Peso Molecular , Músculo Liso/efeitos dos fármacos , Neuropeptídeos/síntese química , Neuropeptídeos/química , Neuropeptídeos/metabolismo , Neuropeptídeos/farmacologia , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/farmacologia , Feromônios/síntese química , Feromônios/química , Feromônios/farmacologia , Estações do Ano , Pele/química , Especificidade da Espécie
2.
Chem Pharm Bull (Tokyo) ; 40(11): 2954-7, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1477910

RESUMO

2,3-Epoxy-4-hydroxy-4-((E,E)-3,6-octadienyl)cyclopentanone (dl-carbacerulenin 5) was synthesized via the epoxyketones 15a and 15b as a mimic of the active form of the antibiotics cerulenin 1, a potent inhibitor of fatty acid synthetase (FAS). The monobenzyl ethers (12 and 13), synthetic intermediates of 15, were prepared by direct benzylation of the epoxycyclopentene (7). Inhibitory activity of synthesized 5 toward yeast FAS was less than that of cerulenin by a factor of 1000.


Assuntos
Cerulenina/análogos & derivados , Ceruletídeo/análogos & derivados , Ácido Graxo Sintases/antagonistas & inibidores , Cerulenina/síntese química , Cerulenina/farmacologia , Ceruletídeo/síntese química , Ceruletídeo/farmacologia , Espectroscopia de Ressonância Magnética , Espectrometria de Massas
3.
Mutagenesis ; 6(3): 185-7, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1881348

RESUMO

Hormone-like peptides are, almost by definition, not mutagenic. It was, therefore, unusual to find that some batches of peptides synthesized by azide coupling were mutagenic in the Ames test. One of these peptides, eledoisin, showed mutagenic activity particularly in Salmonella typhimurium TA 1535 without metabolic activation. This activity was independent of the peptide purity determined by HPLC and a dose response relationship was observed at concentrations over the solubility limit of the peptide in the assay medium. We therefore suggested that the mutagenic effect might be due to the presence of chemically undetectable, water-soluble impurities, which could be removed by counter-current distribution. If, however, the same final coupling was carried out by the mixed anhydride procedure, no mutagenic activity was observed. Consequently, we considered that the mutagenicity detected was due to traces of hydrazoic acid salts arising during azide formation in the coupling step. In fact only the product of the coupling reaction between the pivotal intermediates was mutagenic.


Assuntos
Azidas/farmacologia , Mutagênicos/farmacologia , Peptídeos/síntese química , Sequência de Aminoácidos , Animais , Azidas/isolamento & purificação , Biotransformação , Ceruletídeo/síntese química , Ceruletídeo/isolamento & purificação , Ceruletídeo/farmacologia , Distribuição Contracorrente , Eledoisina/síntese química , Eledoisina/isolamento & purificação , Eledoisina/farmacologia , Dados de Sequência Molecular , Testes de Mutagenicidade , Mutagênicos/isolamento & purificação , Oligopeptídeos/síntese química , Oligopeptídeos/isolamento & purificação , Oligopeptídeos/farmacologia , Peptídeos Opioides , Peptídeos/isolamento & purificação , Peptídeos/farmacologia , Ratos , Salmonella typhimurium/efeitos dos fármacos , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA